See also this year's filing and all EDGAR filings for this company.
PDF Report 0000872589_2011_Regeneron_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000872589, Regeneron Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 357,622,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 347,450,000 |
| 3 | remainder_Assets | 384,360,000 |
| 4 | LiabilitiesCurrent | 109,056,000 |
| 5 | LiabilitiesNoncurrent | 7,350,000 |
| 6 | remainder_Liabilities | 445,211,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 65,201,000 |
| 9 | ResearchAndDevelopmentExpense | 489,252,000 |
| 10 | remainder_Expenses | 2,093,000 |
| 11 | remainder_Revenues | 459,074,000 |
| 12 | remainder_NetIncome | -6,996,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,089,432,000 |
| 1 | Liabilities | 561,617,000 |
| 2 | Expenses | 556,546,000 |
| 3 | Revenues | 459,074,000 |
| 4 | StockholdersEquity | 527,815,000 |
| 5 | NetIncome | -104,468,000 |
| 6 | ComprehensiveNetIncome | -104,468,000 |
| 7 | BaseVar | 1,336,832,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.27 |
| 9 | EconomicCapitalRatio | 2.51 |
Edgar->Model Mapping
Feature Distribution
